Answers are grounded in this paper and cite their sources.
This research demonstrates how ZMYND8 regulates long noncoding RNA MAPT213 in neurons, suggesting insights into gene expression control.
The zinc finger MYND-type containing 8 protein (ZMYND8) is a chromatin reader that regulates neuronal gene expression by controlling the microtubule-associated protein tau (MAPT) locus.Here, we investigate how ZMYND8 regulates expression of the long noncoding RNA MAPT213 through its interaction with GATA zinc finger domain containing 2A (GATAD2A), a component of the Nucleosome Remodelling and Deacetylase (NuRD) complex.ZMYND8 exhibits opposite regulatory effects on protein-coding MAPT and noncoding MAPT213 transcripts in a manner dependent on its MYND domain, promoting MAPT expression while suppressing MAPT213 levels.Chromatin immunoprecipitation experiments demonstrated that ZMYND8 specifically recruits GATAD2A to the MAPT213 internal regulatory region, establishing a direct link between protein binding and transcriptional control.We determined the crystal structure of the ZMYND8 coiled-coil MYND domain at high resolution, revealing a homodimeric architecture.The MYND domain specifically recognizes GATAD2A through direct interaction with proline-rich motifs in GATAD2A's central region.Structure-function analysis identified critical binding interface residues, while quantitative measurements revealed moderate-affinity interactions enhanced through multivalent binding mechanisms.These findings establish the molecular basis for ZMYND8-mediated recruitment of chromatin remodeling complexes to specific genomic loci and provide a structural framework for understanding transcriptional regulation of MAPT213.
No takes yet. Share an insight, caveat, or question.
Srivastava et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: